Navigation Links
Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
Date:12/5/2013

he treatment of certain rheumatology related conditions, and the treatment of infantile spasms (IS) in infants and children under two years of age. With respect to NS, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus." Questcor has announced its intent to initiate a pilot commercialization effort for Acthar for the treatment of respiratory manifestations of symptomatic sarcoidosis. The FDA approved package insert for Acthar includes "symptomatic sarcoidosis" under the heading "Respiratory Diseases."  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need. Questcor also has agreed to acquire certain international rights for Synacthen® (tetracosactide) and Synacthen Depot®, and has licensed the right to develop and seek FDA approval for these products in the United States. For more information about Questcor, please visit www.questcor.com.   


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic
2. Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare
3. Questcor Honored as an "Everyday Hero" by NephCure Foundation
4. Questcor Adds G. Kelly Martin to Board of Directors
5. Questcor Pharmaceuticals to Present at the 2013 Credit Suisse Annual Healthcare Conference
6. Questcor Reports Third Quarter Financial Results
7. Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory Distress Syndrome
8. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
9. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
10. Questcor to Commence Phase 2 Study of Acthar for ALS
11. Questcor to Report Second Quarter Financial Results on July 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a ... technologies and products for advanced microarray diagnostics, today ... Service Agreement to contract with a UK-based company ... the initial phase of this agreement, SQI will ... of one of the customer,s assays, operational on ...
(Date:8/21/2014)... --  Memorial Hermann Health System and The University ... new partnership to provide a new level of specialized breast ... the greater Houston area. ... provider of professional breast radiology services for five of Memorial ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... Texas , Aug. 21, 2014  eRelevance ... services company, announced today that it has completed ... (EMR) solution for Plastic Surgery and Dermatology practices. ... even more value to healthcare practices using Nextech," ... of eRelevance Corporation. "Using information from the EMR ...
Breaking Medicine Technology:SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
(Date:8/22/2014)... 22, 2014 Pirate Jonny's ... products in providing new recipe cards, fun t-shirts, and ... , Hailing from Clearwater, Florida, Pirate Jonny, aka, Jonathan ... card with two to three recipes featuring different flavors ... on the website. The recipe cards will ...
(Date:8/22/2014)... August 22, 2014 Until now, those with ... crutches or walkers to keep mobile. Thanks to an inventor ... much more effective. , He developed a prototype for the ... injured leg or foot but provide comfort and reduce pain ... different heights, it is also convenient and easy to install ...
(Date:8/22/2014)... 2014 The report "Higher Education ... & Compliance, Campus Technology, Student & Curriculum, Performance ... defines and segments the global Higher Ed market ... forecasting of market sizes. The report also identifies ... opportunities impacting it along with the adoption trends. ...
(Date:8/22/2014)... Institutet in Sweden provides insight on how the brain ... from different sources and sides of the body, in ... which are presented in the journal Neuron , ... integrating various types of sensory information, with specialised functional ... is the main input structure in the basal ganglia, ...
(Date:8/22/2014)... dramatic images of nurses at New York University,s Langone ... carrying many including the youngest and most vulnerable down ... the storm surge generated by Hurricane Sandy. , ... York University Colleges of Nursing (NYUCN) and of Dentistry ... examines the impact on NYULMC nurses, post-Sandy deployment ...
Breaking Medicine News(10 mins):Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:The striatum acts as hub for multisensory integration 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3
... Calif., Jan. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... to license rights to SB1518, an orally available, potent, and ... a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore. ... option rights to exclusively develop and commercialize SB1518 (designated by ...
... and SAN DIEGO, Jan. 6 BioMarin,Pharmaceutical Inc. (Nasdaq: ... LJPC ) announced today that they have ... Jolla,s investigational drug for,lupus nephritis, in the United States, ... Asia Pacific region. Following a successful Phase 3,trial, the ...
... wrist at 3T is an effective way to detect wrist ligament ... a study performed at Neuroskeletal Imaging in Merritt Island, Florida. ... and arthroscopy; 51 tears were found on arthroscopy. 41 of the ... 3T MRI is good. We are able to see the small ...
... shoulder allows physicians to better identify tears and provides ... not surgery is needed, according to a study performed ... The study included 150 patients who underwent both 3T ... did the study to see if MR, which is ...
... French . , Recent animal studies ... once used to treat diarrhea and other gastrointestinal disorders ... Huntington,s diseases. Scientists, however, had a variety of theories ... have such similar effects on three unrelated neurodegenerative disorders. ...
... (Nasdaq: WCRX ) today announced that it ... based in Korea, to develop and market their orally-administered ... the treatment of erectile dysfunction (ED) in the United ... of the product in the United States.Under the terms ...
Cached Medicine News:Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 2Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 3Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 4Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 5Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 6Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 7Health News:BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent 8Health News:MR arthrography is more accurate than MR in diagnosing shoulder tears 2Health News:Old gastrointestinal drug slows aging, McGill researchers say 2Health News:Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment 2Health News:Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: